84 related articles for article (PubMed ID: 965044)
1. Plasma angiotensin activity in cirrhosis of the liver and idiopathic portal hypertension.
Dass BK; Chaudhury RR; Chhuttani PN; Saini VK; Datta DV
Indian J Med Res; 1976 Mar; 64(3):418-24. PubMed ID: 965044
[No Abstract] [Full Text] [Related]
2. [The renin-angiotensin system in patients with cirrhosis of the liver].
Serebrovskaia IuA; Loginov AS; Uchitel' IA; Isakova ZS
Ter Arkh; 1971 Dec; 43(12):44-9. PubMed ID: 4334611
[No Abstract] [Full Text] [Related]
3. [Beta-lipoprotein lipids of the human serum in liver diseases. II. Variations in the relative quantity of phospholipids].
Lukesová M; Lukes J
Cas Lek Cesk; 1970 May; 109(21):466-70. PubMed ID: 5444503
[No Abstract] [Full Text] [Related]
4. [Beta-lipoprotein lipids of the human serum in liver diseases. I. Variations in the relative quantity of triglycerides].
Lukesová M; Lukes J
Cas Lek Cesk; 1970 Apr; 109(19):424-8. PubMed ID: 5444773
[No Abstract] [Full Text] [Related]
5. [Changes of serum angiotensionogen concentration in acute hepatitis and liver cirrhosis].
Wernze H; Seki A; Michel H
Klin Wochenschr; 1972 Jan; 50(1):53-5. PubMed ID: 4333778
[No Abstract] [Full Text] [Related]
6. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
[TBL] [Abstract][Full Text] [Related]
7. Normal fibronectin levels after surgical treatment of portal hypertension in liver cirrhosis.
De Angelis V; Zambon M; Toffolo L; Voltan GP; Orazi BM; Santarossa L; Donada C; Zuin R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):89-93. PubMed ID: 1695189
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of the cytopenia syndrome in patients with cirrhosis of the liver complicated by portal hypertension].
Eramishantsev AK; Korshunov IB; Belokrinitskiĭ DV; Dudkina LN; Dem'ianov AI
Khirurgiia (Mosk); 1989 Feb; (2):36-9. PubMed ID: 2709711
[TBL] [Abstract][Full Text] [Related]
9. Estrogens and portal hypertension in cirrhosis of the liver.
Gluud C; Henriksen HH; Svenstrup B
N Engl J Med; 1981 Jan; 304(1):52. PubMed ID: 7432439
[No Abstract] [Full Text] [Related]
10. [Some pathological aspects of the portal hypertension syndrome].
Guimarães JS; Silva Lde C; Goffi FS
AMB Rev Assoc Med Bras; 1968 Jul; 14(7):123-8. PubMed ID: 5304555
[No Abstract] [Full Text] [Related]
11. [Circulation in liver cirrhosis patients and the principles for correcting portal hypertension].
Patsiora MD; Ershov IuA
Khirurgiia (Mosk); 1973 May; 49(5):72-9. PubMed ID: 4795477
[No Abstract] [Full Text] [Related]
12. [Pathogenesis of ascites formation in liver cirrhosis (author's transl)].
Arbeiter G; Meyer-Burg J
Leber Magen Darm; 1974 Oct; 4(6):299-307. PubMed ID: 4373632
[No Abstract] [Full Text] [Related]
13. [Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].
Zhu J; Du R; Leng X
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):144-6. PubMed ID: 9387666
[TBL] [Abstract][Full Text] [Related]
14. [Serum haptoglobins in hepatic cirrhosis with portal hypertension and secondary hypersplenism].
Vai C; Santese R; Andreuzzi B; Gelosa F; Rotondo F
Minerva Dietol Gastroenterol; 1983; 29(4):313-6. PubMed ID: 6672672
[No Abstract] [Full Text] [Related]
15. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Yin J; Leng X; Zhu J
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
La Mura V; Reverter JC; Flores-Arroyo A; Raffa S; Reverter E; Seijo S; Abraldes JG; Bosch J; García-Pagán JC
Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
[TBL] [Abstract][Full Text] [Related]
17. Plasma amino acid patterns in portal hypertensive patients.
Wang MW; Lee XY; Lee H; Sun HK
J Gastroenterol Hepatol; 1989; 4 Suppl 1():259-61. PubMed ID: 2562391
[No Abstract] [Full Text] [Related]
18. [Implications of the arterialization of the sinusoid in its capillarization and in the maintenance of portal hypertension in the cirrhotic patient].
Ceña Lázaro G; Barrao Comps F; Omiste Martínez JL; Ducóns García J; Rojo Puente S; Laquidaín Hergueta M; Bueno Gómez J
Rev Esp Enferm Apar Dig; 1987 Feb; 71(2):111-3. PubMed ID: 3563042
[No Abstract] [Full Text] [Related]
19. [Free amino acids in the serum of portal hypertension patients].
Kataeva GA; Eremenko VP
Vestn Khir Im I I Grek; 1971 Apr; 106(4):10-4. PubMed ID: 5565362
[No Abstract] [Full Text] [Related]
20. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.
Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Gonciarz M; Bielanski W; Reiter RJ; Konturek SJ
J Pineal Res; 2009 May; 46(4):408-14. PubMed ID: 19552764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
